Loading…
Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea
BACKGROUND--The high prevalence of obstructive sleep apnoea (OSA) in patients with systemic hypertension and of hypertension in patients with OSA suggests a causal link between the two disorders. This study was carried out to determine whether nasal continuous positive airway pressure (CPAP) and wei...
Saved in:
Published in: | Thorax 1993-05, Vol.48 (5), p.529-533 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b4209-4f063295493237eb4555b0295b27af657b579f4b9ba259b5f554e9921f69e6d43 |
---|---|
cites | cdi_FETCH-LOGICAL-b4209-4f063295493237eb4555b0295b27af657b579f4b9ba259b5f554e9921f69e6d43 |
container_end_page | 533 |
container_issue | 5 |
container_start_page | 529 |
container_title | Thorax |
container_volume | 48 |
creator | Rauscher, H Formanek, D Popp, W Zwick, H |
description | BACKGROUND--The high prevalence of obstructive sleep apnoea (OSA) in patients with systemic hypertension and of hypertension in patients with OSA suggests a causal link between the two disorders. This study was carried out to determine whether nasal continuous positive airway pressure (CPAP) and weight loss affect daytime hypertension in OSA. METHODS--Sixty hypertensive patients with OSA took part in the study; 33 accepted nasal CPAP and used their machine for 5.7 (0.2) hours per night, and the remaining 27 patients refused nasal CPAP and upper airway surgery so the only therapeutic intervention was a recommendation of weight loss. A significant change in hypertension during follow up was defined as either a change in mean blood pressure of at least 10 mm Hg (or more than 8%) without a change in drug treatment, or a reduction in drug dosage with mean blood pressure within these limits. Weight loss was defined as a body mass index of at least 5% below the baseline value. RESULTS--After 512 (41) days, hypertension had become less severe in seven of 12 patients (58%) treated with weight loss only, in eight of 28 patients (29%) with nasal CPAP only, in two of five patients with nasal CPAP and weight loss, and in one of 15 patients without nasal CPAP or weight loss. Multivariate analysis of variance with the outcome of hypertension at follow up as the dependent variable revealed that only the percentage change in body mass index significantly contributed to the course of hypertension. CONCLUSION--The course of hypertension in OSA is more closely linked to weight loss than to elimination of sleep apnoea by nasal CPAP. |
doi_str_mv | 10.1136/thx.48.5.529 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_464508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3974388771</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4209-4f063295493237eb4555b0295b27af657b579f4b9ba259b5f554e9921f69e6d43</originalsourceid><addsrcrecordid>eNp9ks1rFDEchoModVu9eRUCil6cNd-ZHDyUpbaFUltQD15CMpvpZJ3NjEmmH_99s-yyVA-eAnmfX3iSNwC8wWiOMRWfc3c_Z_WczzlRz8AMM1FXlCjxHMwQYqgSVIqX4DClFUKoxlgegIOaEkIYnoHrS5NMDxdXx1fQhCW8c_6my7AfUoI-wO5hdDG7kPytg6PJ3oWc4J3PHRxsynFq8iZJvXMjNGMYnHkFXrSmT-71bj0CP76efF-cVRffTs8XxxeVZQSpirVIFEvOFCVUOss45xaVDUukaQWXlkvVMqusIVxZ3nLOnFIEt0I5sWT0CHzZnjtOdu2WTTGLptdj9GsTH_RgvP47Cb7TN8OtZoJxVJf5D7v5OPyZXMp67VPj-t4EN0xJS14TQakq4Lt_wNUwxVDuprGUmJIa0Y3Opy3VxPJ20bV7E4z0piddetKs1lyXngr-9qn9Ht4VU_L3u9ykxvRtNKHxaY8xKWuOacGqLeZTdvf72MTfWkgqub78udCn5TP8otdKk8J_3PJ2vfq_4CPmF7Y0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1771328034</pqid></control><display><type>article</type><title>Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea</title><source>PubMed Central(OA)</source><creator>Rauscher, H ; Formanek, D ; Popp, W ; Zwick, H</creator><creatorcontrib>Rauscher, H ; Formanek, D ; Popp, W ; Zwick, H</creatorcontrib><description>BACKGROUND--The high prevalence of obstructive sleep apnoea (OSA) in patients with systemic hypertension and of hypertension in patients with OSA suggests a causal link between the two disorders. This study was carried out to determine whether nasal continuous positive airway pressure (CPAP) and weight loss affect daytime hypertension in OSA. METHODS--Sixty hypertensive patients with OSA took part in the study; 33 accepted nasal CPAP and used their machine for 5.7 (0.2) hours per night, and the remaining 27 patients refused nasal CPAP and upper airway surgery so the only therapeutic intervention was a recommendation of weight loss. A significant change in hypertension during follow up was defined as either a change in mean blood pressure of at least 10 mm Hg (or more than 8%) without a change in drug treatment, or a reduction in drug dosage with mean blood pressure within these limits. Weight loss was defined as a body mass index of at least 5% below the baseline value. RESULTS--After 512 (41) days, hypertension had become less severe in seven of 12 patients (58%) treated with weight loss only, in eight of 28 patients (29%) with nasal CPAP only, in two of five patients with nasal CPAP and weight loss, and in one of 15 patients without nasal CPAP or weight loss. Multivariate analysis of variance with the outcome of hypertension at follow up as the dependent variable revealed that only the percentage change in body mass index significantly contributed to the course of hypertension. CONCLUSION--The course of hypertension in OSA is more closely linked to weight loss than to elimination of sleep apnoea by nasal CPAP.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thx.48.5.529</identifier><identifier>PMID: 8322241</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>Biological and medical sciences ; Body Mass Index ; Female ; Humans ; Hypertension - complications ; Hypertension - therapy ; Male ; Medical sciences ; Middle Aged ; Non tumoral diseases ; Otorhinolaryngology. Stomatology ; Positive-Pressure Respiration ; Sleep Apnea Syndromes - complications ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology ; Weight Loss</subject><ispartof>Thorax, 1993-05, Vol.48 (5), p.529-533</ispartof><rights>1993 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD May 1993</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4209-4f063295493237eb4555b0295b27af657b579f4b9ba259b5f554e9921f69e6d43</citedby><cites>FETCH-LOGICAL-b4209-4f063295493237eb4555b0295b27af657b579f4b9ba259b5f554e9921f69e6d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC464508/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC464508/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4778513$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8322241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rauscher, H</creatorcontrib><creatorcontrib>Formanek, D</creatorcontrib><creatorcontrib>Popp, W</creatorcontrib><creatorcontrib>Zwick, H</creatorcontrib><title>Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea</title><title>Thorax</title><addtitle>Thorax</addtitle><description>BACKGROUND--The high prevalence of obstructive sleep apnoea (OSA) in patients with systemic hypertension and of hypertension in patients with OSA suggests a causal link between the two disorders. This study was carried out to determine whether nasal continuous positive airway pressure (CPAP) and weight loss affect daytime hypertension in OSA. METHODS--Sixty hypertensive patients with OSA took part in the study; 33 accepted nasal CPAP and used their machine for 5.7 (0.2) hours per night, and the remaining 27 patients refused nasal CPAP and upper airway surgery so the only therapeutic intervention was a recommendation of weight loss. A significant change in hypertension during follow up was defined as either a change in mean blood pressure of at least 10 mm Hg (or more than 8%) without a change in drug treatment, or a reduction in drug dosage with mean blood pressure within these limits. Weight loss was defined as a body mass index of at least 5% below the baseline value. RESULTS--After 512 (41) days, hypertension had become less severe in seven of 12 patients (58%) treated with weight loss only, in eight of 28 patients (29%) with nasal CPAP only, in two of five patients with nasal CPAP and weight loss, and in one of 15 patients without nasal CPAP or weight loss. Multivariate analysis of variance with the outcome of hypertension at follow up as the dependent variable revealed that only the percentage change in body mass index significantly contributed to the course of hypertension. CONCLUSION--The course of hypertension in OSA is more closely linked to weight loss than to elimination of sleep apnoea by nasal CPAP.</description><subject>Biological and medical sciences</subject><subject>Body Mass Index</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Hypertension - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Non tumoral diseases</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Positive-Pressure Respiration</subject><subject>Sleep Apnea Syndromes - complications</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><subject>Weight Loss</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNp9ks1rFDEchoModVu9eRUCil6cNd-ZHDyUpbaFUltQD15CMpvpZJ3NjEmmH_99s-yyVA-eAnmfX3iSNwC8wWiOMRWfc3c_Z_WczzlRz8AMM1FXlCjxHMwQYqgSVIqX4DClFUKoxlgegIOaEkIYnoHrS5NMDxdXx1fQhCW8c_6my7AfUoI-wO5hdDG7kPytg6PJ3oWc4J3PHRxsynFq8iZJvXMjNGMYnHkFXrSmT-71bj0CP76efF-cVRffTs8XxxeVZQSpirVIFEvOFCVUOss45xaVDUukaQWXlkvVMqusIVxZ3nLOnFIEt0I5sWT0CHzZnjtOdu2WTTGLptdj9GsTH_RgvP47Cb7TN8OtZoJxVJf5D7v5OPyZXMp67VPj-t4EN0xJS14TQakq4Lt_wNUwxVDuprGUmJIa0Y3Opy3VxPJ20bV7E4z0piddetKs1lyXngr-9qn9Ht4VU_L3u9ykxvRtNKHxaY8xKWuOacGqLeZTdvf72MTfWkgqub78udCn5TP8otdKk8J_3PJ2vfq_4CPmF7Y0</recordid><startdate>19930501</startdate><enddate>19930501</enddate><creator>Rauscher, H</creator><creator>Formanek, D</creator><creator>Popp, W</creator><creator>Zwick, H</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19930501</creationdate><title>Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea</title><author>Rauscher, H ; Formanek, D ; Popp, W ; Zwick, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4209-4f063295493237eb4555b0295b27af657b579f4b9ba259b5f554e9921f69e6d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Biological and medical sciences</topic><topic>Body Mass Index</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Hypertension - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Non tumoral diseases</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Positive-Pressure Respiration</topic><topic>Sleep Apnea Syndromes - complications</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><topic>Weight Loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rauscher, H</creatorcontrib><creatorcontrib>Formanek, D</creatorcontrib><creatorcontrib>Popp, W</creatorcontrib><creatorcontrib>Zwick, H</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rauscher, H</au><au>Formanek, D</au><au>Popp, W</au><au>Zwick, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>1993-05-01</date><risdate>1993</risdate><volume>48</volume><issue>5</issue><spage>529</spage><epage>533</epage><pages>529-533</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>BACKGROUND--The high prevalence of obstructive sleep apnoea (OSA) in patients with systemic hypertension and of hypertension in patients with OSA suggests a causal link between the two disorders. This study was carried out to determine whether nasal continuous positive airway pressure (CPAP) and weight loss affect daytime hypertension in OSA. METHODS--Sixty hypertensive patients with OSA took part in the study; 33 accepted nasal CPAP and used their machine for 5.7 (0.2) hours per night, and the remaining 27 patients refused nasal CPAP and upper airway surgery so the only therapeutic intervention was a recommendation of weight loss. A significant change in hypertension during follow up was defined as either a change in mean blood pressure of at least 10 mm Hg (or more than 8%) without a change in drug treatment, or a reduction in drug dosage with mean blood pressure within these limits. Weight loss was defined as a body mass index of at least 5% below the baseline value. RESULTS--After 512 (41) days, hypertension had become less severe in seven of 12 patients (58%) treated with weight loss only, in eight of 28 patients (29%) with nasal CPAP only, in two of five patients with nasal CPAP and weight loss, and in one of 15 patients without nasal CPAP or weight loss. Multivariate analysis of variance with the outcome of hypertension at follow up as the dependent variable revealed that only the percentage change in body mass index significantly contributed to the course of hypertension. CONCLUSION--The course of hypertension in OSA is more closely linked to weight loss than to elimination of sleep apnoea by nasal CPAP.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>8322241</pmid><doi>10.1136/thx.48.5.529</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0040-6376 |
ispartof | Thorax, 1993-05, Vol.48 (5), p.529-533 |
issn | 0040-6376 1468-3296 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_464508 |
source | PubMed Central(OA) |
subjects | Biological and medical sciences Body Mass Index Female Humans Hypertension - complications Hypertension - therapy Male Medical sciences Middle Aged Non tumoral diseases Otorhinolaryngology. Stomatology Positive-Pressure Respiration Sleep Apnea Syndromes - complications Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology Weight Loss |
title | Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A19%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nasal%20CPAP%20and%20weight%20loss%20in%20hypertensive%20patients%20with%20obstructive%20sleep%20apnoea&rft.jtitle=Thorax&rft.au=Rauscher,%20H&rft.date=1993-05-01&rft.volume=48&rft.issue=5&rft.spage=529&rft.epage=533&rft.pages=529-533&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thx.48.5.529&rft_dat=%3Cproquest_pubme%3E3974388771%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b4209-4f063295493237eb4555b0295b27af657b579f4b9ba259b5f554e9921f69e6d43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1771328034&rft_id=info:pmid/8322241&rfr_iscdi=true |